Indraprastha Medical Corporation Ltd (INDRAMEDCO)
₹305.65
Mkt cap
₹2,802 Cr
P/E ratio
14.60
P/B
3.44
Div yield
1.31%
ROE
27.40%
ROCE
35.80%
EPS (TTM)
₹20.93
Book value
₹89
52W range
294–641
Sector
Healthcare
Price history
Previous close
Incorporated in 1988 as a JV between Apollo Hospitals Enterprise Ltd. (AHEL) and the Delhi Government, Indraprastha Medical Corporation Ltd. is a super speciality tertiary care hospital in New Delhi. The Co. currently has 52 speciality departments. [1]
NSE INDRAMEDCOBSE 532150
Health check
Constructive
ValuationCheap
ProfitabilityStrong
GrowthModerate
TechnicalsBearish
52-week range
−52.31% from high₹306
₹294+4.09% from low₹641
Current
₹305.65
Prev close
₹318.30
Day
−3.97%
Price performance
1D
−4.16%
1W
+1.75%
1M
−14.02%
3M
−15.22%
6M
−24.31%
1Y
−44.49%
YTD
−32.89%
Financials
Revenue, profit & margin
P/E ratio
14.6×
INDRAMEDCO is 67% below the sector median of 44.4×
INDRAMEDCO14.6×
Sector median44.4×
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 317 | 306 | 315 | 348 | 350 | 325 | 334 | 365 | 381 | 372 | 365 | 406 | 413 | |
| Expenses | 267 | 259 | 266 | 281 | 286 | 273 | 272 | 292 | 310 | 310 | 304 | 326 | 335 | |
| Operating Profit | 50 | 47 | 48 | 67 | 64 | 52 | 61 | 73 | 71 | 62 | 61 | 80 | 77 | |
| OPM % | 16% | 15% | 15% | 19% | 18% | 16% | 18% | 20% | 19% | 17% | 17% | 20% | 19% | |
| Other Income | 4 | 4 | 5 | 5 | 6 | 5 | 6 | 7 | 7 | 7 | 7 | 8 | 9 | |
| Interest | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 1 | 2 | 2 | |
| Depreciation | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 10 | 11 | 11 | 11 | 12 | 12 | |
| Profit before tax | 44 | 41 | 42 | 60 | 57 | 45 | 55 | 68 | 66 | 56 | 55 | 75 | 72 | |
| Tax % | 25% | 28% | 25% | 25% | 26% | 26% | 26% | 25% | 25% | 27% | 24% | 25% | 26% | |
| Net Profit | 33 | 29 | 31 | 45 | 42 | 33 | 41 | 51 | 49 | 41 | 42 | 56 | 54 | |
| EPS in Rs | 3.58 | 3.21 | 3.40 | 4.88 | 4.63 | 3.58 | 4.47 | 5.61 | 5.40 | 4.47 | 4.55 | 6.09 | 5.84 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202651.00%Promoter
Promoters51.00%
FIIs2.39%0.38
DIIs1.77%1.18
Public44.83%0.82
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | ₹8,448.00 | 57.74 | 1,21,469 | 0.24% | 610 | +34.17% | 7,044 | +20.56% | 17.45% |
| Manipal Health | ₹669.15 | 99.41 | 88,018 | 0.00% | 243 | −7.86% | 3,091 | +38.12% | 12.10% |
| Max Healthcare | ₹860.00 | 58.93 | 83,705 | 0.23% | 414 | −15.54% | 2,569 | +20.31% | 14.71% |
| Aster DM Quality | ₹681.15 | 164.50 | 59,374 | 0.44% | 29 | −46.12% | 1,311 | +21.60% | 11.57% |
| Fortis Health. | ₹768.15 | 54.36 | 57,992 | 0.13% | 273 | +3.39% | 2,545 | +17.46% | 13.45% |
| Narayana Hrudaya | ₹1,720.20 | 38.85 | 35,154 | 0.26% | 301 | +16.61% | 2,844 | +73.01% | 15.50% |
| Global Health | ₹1,270.30 | 59.66 | 34,156 | 0.04% | 157 | −0.18% | 1,304 | +26.50% | 17.37% |
| Indrapr.Medical | ₹305.65 | 14.58 | 2,802 | 1.31% | 54 | +8.33% | 413 | +8.35% | 35.75% |
| Median: 31 Co. | ₹509.20 | 44.38 | 6,363 | 0.00% | 30 | +17.80% | 403 | +22.28% | 14.62% |
Filings
Annual reports15
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 30 Oct - We hereby submit copies of the public notice of the financial results published on 30th October 2026, in the Financial Express all India edition in …Board Meeting Outcome for Outcome Of Board Meeting- Un-Audited Financial Results For The Quarter Ended 30-09-2026 29 Oct - Board approved unaudited results for quarter and half-year ended 30 September 2026.Board Meeting Intimation for Board Meeting On 29-10-2026 19 Oct - Board meets on 29 Oct 2026 to consider Q2 and half-year unaudited results.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 14 Oct - We hereby submits a certificate dated 6th October 2026, issued by M/s MUFG Intime India Private Limited, Register Transfer Agent of the company,.AGM On 24Th September, 2026-Voting Results And Consolidated Report Of Srutinizer 25 Sep






